Benjamin Hall

Benjamin Hall

Company: Tessera Therapeutics

Job title: Senior Scientist


Considerations for mRNA Potency Assay Development for Gene Editing Products 3:45 pm

Overview of matrix approach for potency assay development Review of available regulatory guidance and expectations for phased-based approach to potency assay development  Tools and considerations when measuring biological cascade of mRNA delivery in vitro  Challenges associated with potency assay development for gene editing products Read more

day: Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.